Barkhof F The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002 Jun;15(3):239-45. Review.
Bartlett TE, Wang YT The intersections of NMDAR-dependent synaptic plasticity and cell survival. Neuropharmacology. 2013 Nov;74:59-68. doi: 10.1016/j.neuropharm.2013.01.012. Epub 2013 Jan 25. Review.
Bliss TV, Lomo T Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973 Jul;232(2):331-56.
Chang PL, Isaacs KR, Greenough WT Synapse formation occurs in association with the induction of long-term potentiation in two-year-old rat hippocampus in vitro. Neurobiol Aging. 1991 Sep-Oct;12(5):517-22.
Comber L, Galvin R, Coote S Gait deficits in people with multiple sclerosis: A systematic review and meta-analysis. Gait Posture. 2017 Jan;51:25-35. doi: 10.1016/j.gaitpost.2016.09.026. Epub 2016 Sep 26. Review.
Compston A, Coles A Multiple sclerosis. Lancet. 2002 Apr 6;359(9313):1221-31. Review. Erratum in: Lancet 2002 Aug 24;360(9333):648.
Duncan ID, Brower A, Kondo Y, Curlee JF Jr, Schultz RD Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6832-6. doi: 10.1073/pnas.0812500106. Epub 2009 Apr 2. Erratum in: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12208. Dosage error in article text.
Li R, Huang FS, Abbas AK, Wigström H Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity. BMC Neurosci. 2007 Jul 26;8:55.
Malenka RC, Nicoll RA NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 1993 Dec;16(12):521-7. Review.
Maletic-Savatic M, Malinow R, Svoboda K Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science. 1999 Mar 19;283(5409):1923-7.
Mattson MP Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. 1988 Apr-Jun;472(2):179-212. Review.
Mostert S, Kesselring J Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler. 2002 Apr;8(2):161-8.
Motl RW, McAuley E Longitudinal analysis of physical activity and symptoms as predictors of change in functional limitations and disability in multiple sclerosis. Rehabil Psychol. 2009 May;54(2):204-10. doi: 10.1037/a0015770.
Ota N, Shi T, Sweedler JV D-Aspartate acts as a signaling molecule in nervous and neuroendocrine systems. Amino Acids. 2012 Nov;43(5):1873-86. doi: 10.1007/s00726-012-1364-1. Epub 2012 Aug 8. Review.
Pau M, Coghe G, Corona F, Marrosu MG, Cocco E Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis. J Neurol Sci. 2015 Nov 15;358(1-2):339-44. doi: 10.1016/j.jns.2015.09.352. Epub 2015 Sep 18.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.
Schirmer L, Merkler D, König FB, Brück W, Stadelmann C Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions. Brain Pathol. 2013 Jan;23(1):2-12. doi: 10.1111/j.1750-3639.2012.00608.x. Epub 2012 Jun 25.
Singer BH, Gamelli AE, Fuller CL, Temme SJ, Parent JM, Murphy GG Compensatory network changes in the dentate gyrus restore long-term potentiation following ablation of neurogenesis in young-adult mice. Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5437-42. doi: 10.1073/pnas.1015425108. Epub 2011 Mar 14.
Stuifbergen AK, Blozis SA, Harrison TC, Becker HA Exercise, functional limitations, and quality of life: A longitudinal study of persons with multiple sclerosis. Arch Phys Med Rehabil. 2006 Jul;87(7):935-43.
Trapp BD, Ransohoff R, Rudick R Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol. 1999 Jun;12(3):295-302. Review.
Tyc F, Boyadjian A Plasticity of motor cortex induced by coordination and training. Clin Neurophysiol. 2011 Jan;122(1):153-62. doi: 10.1016/j.clinph.2010.05.022. Epub 2010 Jun 17.
Wolff JR, Joó F, Dames W Plasticity in dendrites shown by continuous GABA administration in superior cervical ganglion of adult rat. Nature. 1978 Jul 6;274(5666):72-4.
Wolff JR, Missler M Synaptic remodelling and elimination as integral processes of synaptogenesis. APMIS Suppl. 1993;40:9-23. Review.
Ziemann U, Ilic TV, Pauli C, Meintzschel F, Ruge D Learning modifies subsequent induction of long-term potentiation-like and long-term depression-like plasticity in human motor cortex. J Neurosci. 2004 Feb 18;24(7):1666-72. Erratum in: J Neurosci. 2004 Nov 17;24(46):1 p following 10552. Iliac, Tihomir V [corrected to Ilic, Tihomir V].
Promotion of Synaptic Plasticity With D-Aspartate to Favour Recovery Form Cerebral Damage
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.